Urinary angiotensinogen (uAGT) is a novel biomarker of the activation of the renin–angiotensin system (RAAS) in patients with ADPKD, and it is associated with hypertension, progressive kidney damage, proteinuria, and cardiovascular morbidity and mortality. This evidence concerns the gene AGT and autosomal dominant polycystic kidney disease.